Product
Topical treatment designed to improve minoxidil efficacy.

Studies
Clinically shown to increase the enzymes needed for minoxidil to work, sulfotransferase enzymes, by up to 7x over a two-week period.

Sales Channels

Licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, with their commercial launch planned for 2023.

Licensed to India-based Cosmofix Technovation Pvt Ltd and Sanpellegrino Cosmetics with product launch planning underway.

Next Steps
Additional licensing opportunities are being pursued abroad.